vimarsana.com
Home
Live Updates
Gb Sciences to Begin Dosage Study for Its Novel Parkinson's
Gb Sciences to Begin Dosage Study for Its Novel Parkinson's
Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge
LAS VEGAS, April 12, 2022 -- Gb Sciences, Inc. , a leading plant-inspired biopharmaceutical research and development company, has selected the University of Lethbridge in Canada to complete a... | April 12, 2022
Related Keywords
Canada ,
Canadian ,
Mike Albanese ,
Robert Sutherland ,
Canadian Centre ,
Board Of Governors Research ,
University Of Lethbridge ,
Michigan State University ,
National Research Council Of Canada ,
Contract Research Organizations ,
Department Of Neuroscience ,
Exchange Commission ,
Gb Sciences ,
Gb Sciences Inc ,
Gbs Global Biopharma Inc ,
National Research Council Canada ,
Phytomedical Analytics For Research Optimization At Scale ,
Globenewswire Inc ,
Investigational New Drug Application ,
Research Council ,
Gbs Global Biopharma ,
Chief Science Officer ,
Phytomedical Analytics ,
Research Optimization ,
Governors Research Chair ,
Gbs Global ,
Good Manufacturing ,
Cytokine Release Syndrome ,
Contract Research ,
Bruce Wolf Child ,
Sacred Buffalo ,
Post Secondary Learning ,
Blackfoot Confederacy ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Gas ,
Pril ,
022 ,
Tb ,
Reading ,
Iopharmaceutical ,
Research ,
End ,
Development ,
Elected ,
The ,
University ,
F ,
Lethbridge ,
N ,
O ,
Omplete Gblx Us3615441090 ,